400-920-2911 sales@csnpharm.cn
您的位置 : 首页 / Epigenetics / Sirtuin / SRT 2104
CAS No.: 1093403-33-8
Synonyms: GSK-2245840
SRT2104 is an activator of SIRT1 which is involved in the regulation of energy homeostasis.
生物活性
动物研究 | |
剂量 | Mice: 100 mg/kg[1] (p.o.) |
给药途径 | p.o. |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|---|---|---|---|---|
NCT01039909 | Healthy Volunteer ... more >> Atrophy, Muscular Collapse << | Phase 1 | Withdrawn(Subjects were never ... more >>screened/enrolled) Collapse << | February 2011 | - |
NCT01702493 | Psoriasis | Phase 1 | Completed | - | United States, Maryland ... more >> GSK Investigational Site Baltimore, Maryland, United States, 21225 Collapse << |
NCT00920660 | Pulmonary Disease, Chronic Obs... more >>tructive Collapse << | Phase 1 | Completed | - | United Kingdom ... more >> GSK Investigational Site Merthyr Tydfill, Glamorgan, United Kingdom, CF48 4DR Collapse << |
实验方案
技术信息
CAS号 | 1093403-33-8 | 储存条件 |
|
|||||||
分子式 | C26H24N6O2S2 | 运输 | 蓝冰 | |||||||
分子量 | 516.64 | 别名 | GSK-2245840 | |||||||
溶解度 |
|
动物实验配方 |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|
NCT01039909 | Healthy Volunteer ... more >> Atrophy, Muscular Collapse << | Phase 1 | Withdrawn(Subjects were never ... more >>screened/enrolled) Collapse << | February 2011 | - |
NCT01702493 | Psoriasis | Phase 1 | Completed | - | United States, Maryland ... more >> GSK Investigational Site Baltimore, Maryland, United States, 21225 Collapse << |
NCT00920660 | Pulmonary Disease, Chronic Obs... more >>tructive Collapse << | Phase 1 | Completed | - | United Kingdom ... more >> GSK Investigational Site Merthyr Tydfill, Glamorgan, United Kingdom, CF48 4DR Collapse << |
NCT00937326 | Diabetes Mellitus, Type 2 | Phase 2 | Completed | - | - |
NCT01018017 | Diabetes Mellitus, Type 2 | Phase 2 | Completed | - | Germany ... more >> GSK Investigational Site Neuss, Nordrhein-Westfalen, Germany, 41460 Collapse << |
NCT00933530 | Diabetes Mellitus, Type 2 ... more >> Healthy Volunteer Collapse << | Phase 1 | Completed | - | United Kingdom ... more >> GSK Investigational Site Merthyr Tydfill, Glamorgan, United Kingdom, CF48 4DR Collapse << |
NCT01031108 | Diabetes Mellitus, Type 2 | Phase 1 | Completed | - | United Kingdom ... more >> GSK Investigational Site Edinburgh, United Kingdom, EH16 4SB Collapse << |
NCT01154101 | Psoriasis | Phase 2 | Completed | - | United States, Missouri ... more >> GSK Investigational Site Saint Louis, Missouri, United States, 63117 United States, New York GSK Investigational Site New York, New York, United States, 10016 GSK Investigational Site New York, New York, United States, 10065 United States, Oregon GSK Investigational Site Portland, Oregon, United States, 97223 United States, Pennsylvania GSK Investigational Site Philadelphia, Pennsylvania, United States, 19103 United States, Rhode Island GSK Investigational Site Johnston, Rhode Island, United States, 02919 United States, Texas GSK Investigational Site Dallas, Texas, United States, 75246 United States, Washington GSK Investigational Site Seattle, Washington, United States, 98101 Collapse << |
NCT00964340 | Atrophy, Muscular | Phase 1 | Completed | - | United Kingdom ... more >> GSK Investigational Site London, United Kingdom, W12 0HS Collapse << |
NCT01154101 | - | - | Completed | - | - |
NCT00938275 | Diabetes Mellitus, Type 2 | Phase 1 | Completed | - | United Kingdom ... more >> GSK Investigational Site Merthyr Tydfill, Glamorgan, United Kingdom, CF48 4DR Collapse << |
NCT00933062 | Diabetes Mellitus, Type 2 | Phase 1 | Completed | - | United Kingdom ... more >> GSK Investigational Site Merthyr Tydfill, Glamorgan, United Kingdom, CF48 4DR Collapse << |
NCT00937872 | Diabetes Mellitus, Type 2 | Phase 1 | Completed | - | United Kingdom ... more >> GSK Investigational Site Nottingham, United Kingdom, NG11 6JS Collapse << |
NCT00937326 | - | - | Completed | - | - |
NCT01014117 | Sepsis | Phase 1 | Completed | - | Netherlands ... more >> GSK Investigational Site Amsterdam, Netherlands, 1105 AZ Collapse << |
NCT01453491 | Colitis, Ulcerative | Phase 1 | Completed | - | United States, California ... more >> GSK Investigational Site Anaheim, California, United States, 92801 United States, Connecticut GSK Investigational Site Bristol, Connecticut, United States, 06010 United States, Kentucky GSK Investigational Site Owensboro, Kentucky, United States, 42303 United States, Maryland GSK Investigational Site Chevy Chase, Maryland, United States, 20815 GSK Investigational Site Towson, Maryland, United States, 21204 United States, Michigan GSK Investigational Site Chesterfield, Michigan, United States, 48047 United States, New York GSK Investigational Site Great Neck, New York, United States, 11021 GSK Investigational Site New York, New York, United States, 10029 United States, North Carolina GSK Investigational Site Raleigh, North Carolina, United States, 27612 United States, Ohio GSK Investigational Site Beavercreek, Ohio, United States, 45432 GSK Investigational Site Columbus, Ohio, United States, 43215 United States, Oklahoma GSK Investigational Site Oklahoma City, Oklahoma, United States, 73104 United States, Tennessee GSK Investigational Site Jackson, Tennessee, United States, 38305 Collapse << |
联系我们
官方电话:400-920-2911
二维码
微信公众号 CSN官网